相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Fasting C-peptide, a biomarker for hypoglycaemia risk in insulin-naive people with type 2 diabetes initiating basal insulin glargine 100 U/mL
Wolfgang Landgraf et al.
DIABETES OBESITY & METABOLISM (2020)
Switching from Premixed Insulin To Basal Insulin Analogue For Type 2 Diabetes and Role of Dipeptidyl Peptidase-4 Inhibitors
Fernando Gomez-Peralta et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2018)
Stratification of type 2 diabetes based on routine clinical markers
Narges Safai et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2018)
Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables
Emma Ahlqvist et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
Switching From Pre-mixed Insulin to Regimens with Insulin Glargine in Type 2 Diabetes: A Prospective, Observational Study of Data From Adriatic Countries
Goran Petrovski et al.
DIABETES THERAPY (2018)
Switching From Pre-mixed Insulin to Regimens with Insulin Glargine in Type 2 Diabetes: A Prospective, Observational Study of Data From Adriatic Countries
Goran Petrovski et al.
DIABETES THERAPY (2018)
Glycemic control and safety in Chinese patients with type 2 diabetes mellitus who switched from premixed insulin to insulin glargine plus oral antidiabetics: a large, prospective, observational study
Bo Zhang et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2017)
Insulin adherence and persistence among Chinese patients with type 2 diabetes: a retrospective database analysis
Xiaoning He et al.
PATIENT PREFERENCE AND ADHERENCE (2017)
A Practical Review of C-Peptide Testing in Diabetes
Emma Leighton et al.
DIABETES THERAPY (2017)
A Practical Review of C-Peptide Testing in Diabetes
Emma Leighton et al.
DIABETES THERAPY (2017)
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM-2017 EXECUTIVE SUMMARY
Alan J. Garber et al.
ENDOCRINE PRACTICE (2017)
Standards of care for type 2 diabetes in China
Jianping Weng et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2016)
Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
Silvio E. Inzucchi et al.
DIABETOLOGIA (2015)
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
Silvio E. Inzucchi et al.
DIABETES CARE (2015)
Physiological effects and therapeutic potential of proinsulin C-peptide
Gina L. C. Yosten et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2014)
Efficacy of switching from premixed insulin to insulin glargine regimen in Type 2 diabetes mellitus patients with different islet functions
Yong-Bo Wang et al.
MOLECULAR MEDICINE REPORTS (2014)
Clinical study of treatment switching from premixed insulin to basal insulin combined with oral hypoglycemic drugs in patients with type 2 diabetes
Ying Zhang et al.
DIABETOLOGY & METABOLIC SYNDROME (2014)
The clinical utility of C-peptide measurement in the care of patients with diabetes
A. G. Jones et al.
DIABETIC MEDICINE (2013)
SWITCHING FROM PREMIXED INSULIN TO BASAL-BOLUS INSULIN GLARGINE PLUS RAPID-ACTING INSULIN: THE ATLANTIC STUDY
C. Mathieu et al.
ACTA CLINICA BELGICA (2013)
Short-term intensive insulin therapy in type 2 diabetes mellitus: a systematic review and meta-analysis
Caroline Kaercher Kramer et al.
LANCET DIABETES & ENDOCRINOLOGY (2013)
A prospective study to optimize insulin treatment by switching to insulin glargine in type 2 diabetic patients previously uncontrolled on premixed insulin: the optimization study
Wenying Yang et al.
CURRENT MEDICAL RESEARCH AND OPINION (2012)
Once-daily initiation with biphasic insulin aspart 30 versus insulin glargine in patients with type 2 diabetes inadequately controlled with oral drugs: an open-label, multinational RCT
Krzysztof Strojek et al.
CURRENT MEDICAL RESEARCH AND OPINION (2009)
Optimal insulin regimens in type 2 diabetes mellitus: systematic review and meta-analyses
D. S. Lasserson et al.
DIABETOLOGIA (2009)
Insulin glargine-based therapy improves glycemic control in patients with type 2 diabetes sub-optimally controlled on premixed insulin therapies
Melanie Davies et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2008)
Targets and tactics: the relative importance of HbA(1c), fasting and postprandial plasma glucose levels to glycaemic control in type 2 diabetes
V. Woo et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2008)
Effect of intensive insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes:: a multicentre randomised parallel-group trial
Jianping Weng et al.
LANCET (2008)
Patients with type 2 diabetes inadequately controlled on premixed insulin: effect of initiating insulin glargine plus oral antidiabetic agents on glycaemic control in daily practice
H. Hammer et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2007)
Efficacy and treatment satisfaction of once-daily insulin glargine plus one or two oral antidiabetic agents versus continuing premixed human insulin in patients with type 2 diabetes previously on long-term conventional insulin therapy:: The switch pilot study
R. Schiel et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2007)
Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: An evidence-based comparison
Liza L. Ilag et al.
CLINICAL THERAPEUTICS (2007)
Hypoglycemic events and glycosylated hemoglobin values in patients with type 2 diabetes mellitus newly initiated on insulin glargine or premixed insulin combination products
Michael F. Bullano et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2006)
Premixed insulin analogues for the treatment of diabetes mellitus
AJ Garber
DRUGS (2006)
Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes
HU Janka et al.
DIABETES CARE (2005)
分享论文
